How much funding has PRIVO TECHNOLOGIES, LLC raised?

PRIVO TECHNOLOGIES, LLC has raised $6.4M in total funding, most recently a Grant round.

When was PRIVO TECHNOLOGIES, LLC founded?

PRIVO TECHNOLOGIES, LLC was founded in 2015.

Where is PRIVO TECHNOLOGIES, LLC headquartered?

PRIVO TECHNOLOGIES, LLC is headquartered in Cambridge, Massachusetts, United States.

What industry is PRIVO TECHNOLOGIES, LLC in?

PRIVO TECHNOLOGIES, LLC operates in Biotech, Healthcare.

How many employees does PRIVO TECHNOLOGIES, LLC have?

PRIVO TECHNOLOGIES, LLC has 1-10 employees.

PRIVO TECHNOLOGIES, LLC

Phase 3 Oncology Biotech Company

Cambridge, United States · Founded 2015 · $6.4M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 1–10
Founded: 2015
Business Model: B2G

Website: privotechnologies.com
Total Funding: $6.4M
Last Round: $2.5M GrantFeb 2022

About

PRIVO TECHNOLOGIES LLC is a nanoparticle drug delivery company focused on developing non-invasive therapeutic platforms for oncology applications. The company has advanced a nanoengineered cisplatin-releasing patch (PRV-111) into Phase II clinical trials for noninvasive treatment of oral cancer and high-grade dysplasia, funded through multiple SBIR/STTR awards from NIH and NSF.

Summary

PRIVO TECHNOLOGIES, LLC is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $6.4M in total, most recently a $2.5M Grant round in Feb 2022.